BIOLOGY AND MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
BIOLOGY AND MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
批准号:
2568932
负责人:
S M FEINSTONE
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Pan antitumor antibody complementary DNA cytotoxic T lymphocyte genome hepatitis C hepatitis C virus hepatocellular carcinoma histocompatibility gene histocompatibility typing human subject human tissue liver cells neoplasm /cancer immunology polymerase chain reaction tissue /cell culture tumor antigens tumor suppressor genes viral carcinogenesis virus genetics virus protein virus related neoplasm /cancer virus replication
中文摘要
我们已经构建了一个推定的全长cDNA克隆的基因组,
已经在细胞培养和通过RNA直接转染中进行了评估
复制到黑猩猩的肝脏中。 而原来的
克隆没有传染性,赖斯最近准备了新的克隆,
添加了额外的序列。 这些建筑目前正在
评估。 体外细胞培养实验继续主要使用
肝细胞系THLE5b。 我们已经证明了
通过6代的定量PCR复制HCV,但失败
来显示任何复制的增长水平,事实上已经失去了
病毒在这种水平上。 这些实验正在重复。 在
为了改善细胞培养中的复制,我们表达了
细胞中的各种HCV非结构蛋白如聚合酶
希望过表达可以提高复制。 作为
肝细胞癌是慢性HCV最严重的并发症
感染,我们已经开始实验,试图了解
病毒与致癌作用的关系。 我们研究了
p53和RB肿瘤抑制因子的所有单个HCV特异性蛋白
抗原 这些实验得到了很好的控制,但没有显示出特异性。
我们也没有证明HCV对p53和RB的切割
蛋白酶 我们也在寻找肝细胞癌(HCC)
因为我们发现,四分之三的患者,
HCC具有针对肝癌衍生细胞表面的抗体
线 由于我们也对肝癌的CTL应答感兴趣,我们进行了HLA分型,
7个HCC来源的细胞系,但发现6个具有下调的HLA
I类,只有一个等位基因的HLA A基因座表达。 我们
直接从HCC组织中分离CTL,并在HLA相容的
HCC细胞系作为靶。 已建立的CTL系将用于
鉴定编码HCC抗原的特异性基因。
英文摘要
We have constructed a putative full length cDNA clone of the genome that
has been evaluated in both cell culture and by direct transfection of RNA
transcripts of this clone into chimpanzee liver. While the original
clone was not infectious, Rice has recently prepared new clones in which
additional sequence has been added. These constructs are presently being
evaluated. In vitro cell culture experiments continue using primarily
a liver cell line, THLE5b. We have demonstrated the low level
replication of HCV by quantitative PCR through 6 passages but have failed
to show any increasing levels of replication and in fact have lost the
virus at that passage level. These experiments are being repeated. In
order to improve the replication in cell culture we are expressing
various HCV non-structural proteins such as the polymerase in the cell
cultures in the hopes that over expression may improve replication. As
hepatocellular carcinoma is the most serious complication of chronic HCV
infection, we have initiated experiments to try to understand the
relationship of the virus to carcinogenesis. We have studied binding of
all the individual HCV specific proteins to p53 and RB tumor suppressor
antigens. These experiments were well controlled but showed no specific
binding nor have we demonstrated cleavage of p53 and RB by the HCV
proteases. We are also looking for hepatocellular carcinoma (HCC)
specific tumor antigens as we have found that 3 out of four patients with
HCC have antibodies directed at the surface of hepatoma derived cell
lines. As we are also interested in CTL responses to HCC, we HLA typed
7 HCC derived cell lines but found that 6 had had down regulated HLA
class I and only one allele of the HLA A-locus was expressed. We are
isolating CTL directly from HCC tissue and testing them on HLA compatible
HCC cell lines as targets. Established CTL lines will be used to
identify specific genes coding for the HCC antigen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HYBRIDOMA ANTIBODIES TO PATHOGENIC VIRUSES
-
批准号:4688459
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:
HEPATITIS C VIRUS NEUTRALIZATION METHOD DEVELOPMENT
-
批准号:6101194
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
STRUCTURAL AND ANTIGENIC ANALYSIS OF HEPATITIS A VIRUS
-
批准号:3960537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:
ANTIGENIC STRUCTURE OF HEPATITIS A VIRUS
-
批准号:3792556
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
ANTIGENIC STRUCTURE OF HEPATITIS A VIRUS
-
批准号:3811272
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
ANTIGENIC STRUCTURE OF HEPATITIS C VIRUS
-
批准号:2568931
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
NON-A NON-B HEPATITIS
-
批准号:3811274
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
BIOLOGY AND MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
-
批准号:5200721
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
ANTIGENIC STRUCTURE OF HEPATITIS C VIRUS
-
批准号:3770325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
BIOLOGY AND MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
-
批准号:3770326
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
NON-A NON-B HEPATITIS
-
批准号:3804830
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
BIOLOGY OF NON-A, NON-B HEPATITIS AGENTS
-
批准号:3818186
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:
BIOLOGY OF NON-A, NON-B HEPATITIS AGENTS
-
批准号:3960542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:
ANTIGENIC STRUCTURE OF HEPATITIS A VIRUS
-
批准号:3804829
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
ANTIGENIC STRUCTURE OF HEPATITIS C VIRUS
-
批准号:6161255
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
ANTIGENIC STRUCTURE OF HEPATITIS C VIRUS
-
批准号:6101190
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
ANTIGENIC STRUCTURE OF HEPATITIS C VIRUS
-
批准号:5200720
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
BIOLOGY OF NON-A, NON-B HEPATITIS AGENTS
-
批准号:4688465
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:
HEPATITIS C
-
批准号:3792558
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
MOLECULAR CHARACTERIZATION OF HAV
-
批准号:3811273
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S M FEINSTONE
-
依托单位:--
海外基金